Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.
Leuk Res
; 32(2): 353-5, 2008 Feb.
Article
em En
| MEDLINE
| ID: mdl-17825907
ABSTRACT
Philadelphia positive (Ph+) chronic myeloid leukaemia (CML) presenting synchronously or following non-Hodgkin lymphoma (NHL) has only rarely been reported. Herein, we refer on a case of Ph+ CML occurring after a breast cancer and a NHL with multiple relapses. After obtaining complete cytogenetic remission with imatinib, the patient presented a new NHL relapse, that was treated with rituximab concomitantly to imatinib. Therapy was well tolerated and the patient is presently alive in complete remission of either NHL and CML. We also reviewed the literature relating the uncommon association of these two unrelated diseases.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Linfoma não Hodgkin
/
Neoplasias da Mama
/
Leucemia Mielogênica Crônica BCR-ABL Positiva
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Segunda Neoplasia Primária
Tipo de estudo:
Risk_factors_studies
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Leuk Res
Ano de publicação:
2008
Tipo de documento:
Article
País de afiliação:
Itália